WaveForm Technologies Inc.

About WaveForm Technologies Inc.

WaveForm Technologies specializes in continuous glucose monitoring (CGM) solutions designed to provide real-time glucose data every minute. The company aims to empower individuals managing diabetes by offering a 14-day continuous glucose monitoring system that is both innovative and user-friendly. WaveForm Technologies operates in the healthcare sector, primarily serving individuals with diabetes who seek better control over their glucose levels. The business model revolves around the sale of CGM devices and related services, generating revenue through direct sales and international distribution agreements. Notably, the company has entered commercial agreements with A. Menarini Diagnostics S.r.l. for international distribution and has received CE Mark approval for its CGM system. WaveForm's unique, needle-free sensor applicator makes the insertion process virtually painless, and the system includes predictive alerts to notify users 15 minutes before a high or low glucose event. Clinical trials have demonstrated the reliability and effectiveness of their products, further establishing their credibility in the market.